NEW YORK (GenomeWeb News) – European Union regulators have extended their review deadline to Jan. 20 from the previous Jan. 6 on the proposed acquisition of Varian by Agilent Technologies.
According to a Reuters report today, EU regulators extended the deadline to make a decision on the deal after Agilent agreed to remedies for competition concerns. Those remedies were not specified, and Agilent officials did not return a call seeking comment before this article was published.
Agilent had reached an agreement in July to acquire Varian for around $1.5 billion. The firms said at the time that they expected to close the deal before the end of this year.
In September, the US Federal Trade Commission asked Varian and Agilent for additional information in connection with the proposed merger.